NCT00653120View on ClinicalTrials.gov

Bioavailability Study of Propranolol Under Fasting Conditions

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Propranolol

ER capsules, 160 mg, single-dose

DRUG

Inderal-LA

ER capsules, 160 mg, single-dose

Trial Locations (1)

G1V2K8

SFBC Anapharm, Sainte-Foy

Sponsors
All Listed Sponsors
collaborator

SFBC Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY